Mereo BioPharma
Mereo BioPharma is a clinical-stage company focused on developing & commercialising rare disease & oncology treatments.
45 employees · est. 2015 · London, United Kingdom
Mereo BioPharma is the older company (2016 vs 2015); Apollo Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Apollo Therapeutics | Mereo BioPharma |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2015 older |
| Headquarters | ||
| Headquarters | Not tracked yet | London, United Kingdom |
| Employees | ||
| Employees | 59 larger | 45 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series C | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $313.50M | $373.90M |
| Funding Rounds | ||
| Funding Rounds | 4 | 6 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Therapeutic Programs, Drug Development, Pipeline, Oncology, Inflammatory Disorders, Rare Disease, University Partnerships, Accelerated Drug Development, Capital Efficiency, Clinical Development, Venture Funding, Global Collaborations, Biotech Innovation, Expanding Operations | Mereo BioPharma, Biopharmaceutical Company, Oncology Therapeutics, Rare Disease Therapeutics, Etigilimab, Setrusumab, Alvelestat, Clinical Trials, Phase 1a Trial, Phase 2b Trial, COVID-19 Research, Anti-TIGIT, Nivolumab, Osteogenesis Imperfecta, Alpha-1 Antitrypsin Deficiency |
| Website | ||
| Website | apollotherapeutics.com | mereobiopharma.com |
About Apollo Therapeutics
Apollo Therapeutics is a burgeoning biopharmaceutical company that is rapidly advancing a robust pipeline of potentially transformative therapeutic programs based on breakthrough discoveries. Founded in 2016, the company's innovative model was created in late 2015 by three world-leading universities...
About Mereo BioPharma
Mereo Biopharma is a clinical-stage company focused on developing and commercializing rare disease and oncology treatments. Since its founding in 2015, the company has demonstrated an agile and purpose-driven approach to bring novel therapies to market. Through acquisitions from Novartis and AstraZe...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Apollo Therapeutics and Mereo BioPharma — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Apollo Therapeutics and Mereo BioPharma — by email.
Frequently Asked Questions
Compare Apollo Therapeutics with someone else
Start typing a company name or domain.